Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Internationally Recognized Certificates of Compliance
(IRCC)
last updated: 05 Apr 2016
ABSCH-IRCC-IN-206806-1
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndiaPhone: +91 44 2254 2777,Fax: +91 44 2254 1200,Website: http://www.nbaindia.org,
India/NBA/Appl/9/593
Application in Form-III for seeking approval for the invention " Ayurvedic medicinal tablet and capsules process and formulation" for obtaining IP Rights in India.
06 Mar 2015
Yes
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndiaPhone: +91 44 2254 2777,Fax: +91 44 2254 1200,Website: http://www.nbaindia.org,
Confidential information
Person:Mr Nilesh Madhusudan PagedarIndividual (I)D/6, Pragnya Nagar Scoiety, Newar Kaladarshan Char rasta, Waghodi Road,Vadodara, Gujarat
, IndiaPhone: +91 942601449,Fax:Email: npagesdar@yahoo.com,Website:
Confidential information
Yes
1. The user shall notify the NBA on the grant of IPR within 30 days from the grant.
2. In case the applicant commercializes the innovation/ process/ product himself:
2. In case the applicant commercializes the innovation/ process/ product himself:
- The applicant shall pay royalty @ 3% of the highest ex-factory sale price of the Product(s) sold or used for captive consumption.
For obtaining the IP Rights on the Invention " Ayurvedic medicinal tablet & capsules process and formulation" in India
Bioresources used: Castor leaves powder and Cow milk
Confidential information
- Commercial
If the Applicant assigns/licenses the innovation/ process/ product to a third party for commercialization:
The Applicant shall pay 5% of the fee received by him in any form (including the license fee / assignee fee). He shall also pay 5% of the annual royalty amount received by him, on an annual basis, from the assignee/ licensee throughout the term of the agreement.
[OR]
The assignee/licensee shall enter into a tripartite agreement with the Applicant and the NBA, to pay 5% of the lump sum payment made by him to the licensor and also royalty @ 5% of the highest ex-factory sale price of the product sold and also used for captive consumption to NBA.
| Unique identifier | Status | Date |
|---|---|---|
| ABSCH-IRCC-IN-206806-1 |
REVOKED
OLD VERSION
PUBLISHED
DELETED
|
Hem Pande (hempande@nic.in)
05 Apr 2016 09:10 on 05 Apr 2016 09:10
|
